Skin cancer risk and the use of UV nail lamps
In recent years, there has been a vogue towards the use of acrylic gel manicures due to their lustre, shine and resistance to chipping. Gel nails require UV light for polymerization and hardening, with the typical exposure time per manicure being 5 min per hand, with repeated treatments required every 2-3 weeks. UV nail lamps have similar properties to traditional UV tanning sunbeds, with most of the light emitted from UV-A radiation.
Current evidence on the carcinogenic risk associated with nail lamps is controversial. This work aimed to assess the knowledge of the public about nail lamps as a potential source of UV radiation. An anonymous online survey was distributed to members of the public to evaluate patterns of use of UV nail lamps, awareness of a potential carcinogenic risk and attitudes towards UV exposure.
Of the 424 individuals who responded, 415 (98%) were women. The mean age of respondents was 28.3 AE 6.1 years. Two-thirds (286, 68%) had previously had a gel manicure and one in eight (13%) had this repeated more than once a month. In all, 36 (9%) respondents believed there was a cancer risk with a light emitting diode nail lamp, whereas 227 (53.5%) were unsure. Altogether 306 respondents (72%) believed there was a cancer risk with a UV nail lamp. Four of five participants (82%) reported that they would not proceed with a gel manicure if they knew there was an associated risk.
There have been observational case reports linking the use of these lamps to the development of skin cancer on the hand. 1 However, the risk associated with these lamps has yet to be truly established. This is further confounded by the multitude of different available brands and the fact that different bulbs are in use, given the commercial availability of both light emitting diode and UV bulbs. Diffey's 2 mathematical model concluded that tens or hundreds of thousands of individuals would need to use one of these lamps regularly for one to develop a squamous cell carcinoma on the dorsum of the hands. Dowdy and Sayre 3 studied the photobiological safety of six lamps and determined that the daily acceptable usage times ranged from 36 min to over 4.5 h. Similarly, Markova and Weinstock 4 reported that at least 13 700 nail lamp sessions would be required to equal the exposure of one phototherapy session. These studies support the assumption that the exposure risk is negligible, as even the most avid user would struggle to reach these thresholds.
However, other studies suggest that the risk may be more clinically significant. Shipp and colleagues 5 assessed 17 different nail lamps and calculated that the threshold for DNA damage could be reached between 8 and 208 visits to a salon. Curtis and colleagues 6 suggested that in less than 10 min the hands could receive an energy dose equivalent to the recommended limit for an entire day. These studies suggest that the risk posed by these devices should be taken seriously.
This variation in the literature is reflected in our results. A large proportion of respondents were unsure, when asked if there was a cancer risk associated with either light emitting diode or UV nail lamps.
The Skin Cancer Foundation in the USA and the American Academy of Dermatology, recommend that prior to a gel manicure, clients should apply a broad-spectrum Conflict of interest: none.
sunscreen to the hands. 7 Only 3% of respondents to our survey applied sunscreen prior to receiving a manicure. In addition, only two respondents reported that they had been advised by the nail salon to apply sunscreen prior to the treatment. This suggests that those performing the nail treatment are also unaware of the radiation potential. In summary, these results demonstrate that the public appears to be confused about the carcinogenic potential of these nail lamps. The evidence on this subject is variable and often controversial, leaving the health-care provider with no clear conclusion, and further research is warranted. In the interim, we agree with the advice that approximately 20 min before having a manicure a broad spectrum, high sun protection factor sunscreen is applied to the hands, or the use of fingerless gloves should be considered. 
Heterogeneity in skin manifestations of spotted fever group rickettsial infection in Australia
Skin changes are important early features of spotted fever group rickettsial infection. Unfortunately, the distribution and morphological features are often non-specific and highly variable, in the absence of eschar. 1 Moreover, newly administered medications, such as antibiotics and analgesics in the setting of acute febrile illness further complicates correct diagnosis. Serological testing remains the gold standard for clinical diagnosis; however, it is often imperfect and antibody cross-reactivity and false-positive results are not uncommonly seen. 1 Skin morphological and histopathological characteristics of acute spotted fever group rickettsial infection are poorly described in the current literature. Furthermore, the utility of a skin biopsy in diagnosis has yet to be determined. Case report and series data have documented a wide variety of cutaneous morphological features including macular, maculopapular, vesicular, pustular, purpuric and petechial exanthem, all at different time points and with different severities of illness. [2] [3] [4] Symptoms include both pruritis and pain; however, most are asymptomatic. 5 Rickettsia are known to replicate within endothelial cells and tissue macrophages, which can cause disseminated vasculitis, purpura fulminans, Stevens-Johnson syndrome and widespread skin necrosis (Fig. 1) . 2 We report retrospectively on the skin manifestations of 36 patients presenting to five hospitals in south-east Queensland with a serologically confirmed spotted fever group rickettsia infection. Of the 36 patients 30 (83%) had documented cutaneous involvement, and of the latter 12 (36%) underwent a skin biopsy. With regard to morphology, a maculopapular eruption was reported in most of these patients (21/30; 70%); while a macular, vesicular and purpura rash was found in 17, 10 and 3% of this group, respectively. A non-blanching rash was reported in 6/30 (20%) patients (Fig. 2) . Eschar was noted in 6/30 (20%) and a visible tick bite was seen in 17/30 (57%). The distribution of the cutaneous changes was mainly global (21/30; 70%); while it was found on the lower limbs, upper limbs and trunk of 13, 10 and 7% of these patients, respectively. The body distribution of the rash appeared to reflect Figure 1 Widespread dermal necrosis and distal limb ischaemia secondary to severe sepsis from acute spotted fever group rickettsial infection. Conflict of interest: none.
